426
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Fetal gene therapy: recent advances and current challenges

, , , &
Pages 1257-1271 | Published online: 31 May 2011

Bibliography

  • Genetic Disease Information. Human Genome Project Information Washington, DC: U.S. Department of Energy Genome Programs, 2008. Available from: http://www.ornl.gov/sci/techresources/Human_Genome/medicine/assist.shtml [Last accessed 18 May 2011]
  • Weatherall D, Akinyanju O, Fucharoen S, Inherited Disorders of Hemoglobin. In: Jamison DT, Breman JG, Measham AR, , editors, Disease Control Priorities in Developing Countries. 2nd edition. Oxford University Press; New York; 2006. p. 663-680
  • Kulkarni R, Chitlur M, Lusher JM. Treatment of Congenital Coagulopathies. In: Mintz P, editor, Transfusion Therapy: Clinical Principles and Practice. 3rd edition. AABB Press; Bethesda, MD; 2011:121-40
  • Meikle PJ, Hopwood JJ, Clague AE, Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54
  • Powers JM, Moser HW. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 1998;8:101-20
  • Peters C, Steward CG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 2003;31:229-39
  • Lo YMD, Chiu RWK. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8:71-7
  • Sabatino DE, Mackenzie TC, Peranteau W, Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol Ther 2007;15:1677-85
  • Manno CS, Pierce GF, Arruda VR, Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006;12:342-7
  • Porada CD, Park PJ, Almeida-Porada G, Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer. Mol Ther 2005;11:284-93
  • Goodnow CC, Sprent J, Fazekas de St Groth B, Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005;435:590-7
  • Nakai H, Thomas CE, Storm TA, A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J Virol 2002;76:11343-9
  • Nathwani AC, Gray JT, McIntosh J, Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood 2007;109:1414-21
  • Kay MA, Manno CS, Ragni MV, Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000;24:257-61
  • Herzog RW, Yang EY, Couto LB, Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999;5:56-63
  • Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126:555-64
  • Guillot PV, Gotherstrom C, Chan J, Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres Than adult MSC. Stem Cells 2007;25:646-54
  • Endo M, Henriques-Coelho T, Zoltick PW, The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors. Gene Ther 2010;17:61-71
  • Schachtner S, Buck C, Bergelson J, Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Ther 1999;6:1249-57
  • Turkay A, Saunders T, Kurachi K. Intrauterine gene transfer: gestational stage-specific gene delivery in mice. Gene Ther 1999;6:1685-94
  • Brightman MW, Klatzo I, Olsson Y, The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 1970;10:215-39
  • Waddington SN, Nivsarkar MS, Mistry AR, Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 2004;104:2714-21
  • Seppen J, van der Rijt R, Looije N, Long-term correction of bilirubin UDP glucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 2003;8:593-9
  • Karolewski BA, Wolfe JH. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII. Mol Ther 2006;14:14-24
  • Rucker M, Fraites TJ Jr, Porvasnik SL, Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 2004;131:3007-19
  • Dejneka NS, Surace EM, Aleman TS, In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 2004;9:182-8
  • Williams M, Coleman J, Haire S, Lentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindness PLoS Med 2006;3(10):e201
  • Niiya M, Endo M, Shang D, Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther 2009;17:34-41
  • Koppanati B, Li J, Reay D, Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene. Gene Ther 2010;17:1-8
  • Reay D, Bilbao R, Koppanati B, Full-length dystrophin gene transfer to the mdx mouse in utero. Gene Ther 2008;15:531-6
  • Buckley SMK, Waddington SN, Jezzard S, Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice. Mol Ther 2008;16:819-24
  • Davies L, Varathalingam A, Painter H, Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol Ther 2008;16:812-18
  • Roybal JL, Endo M, Radu A, Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model. Gene Ther 2011 [Epub ahead of print]; doi: 10.1038/gt.2011.23
  • Harkness J, Wagner J. The Biology and Medicine of Rabbits and Rodents. 4th edition. Williams & Wilkins, Philadelphia; 1995
  • Georgiadesa P, Ferguson-Smith A, Burton G. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 2002;23:3-19
  • Holladay SD, Smialowicz RJ. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environ Health Perspect 2000;108(Suppl 3):463-73
  • Verlarde A, Cooper M. An immunofluorescence analysis of the ontogeny of myeloid, T, and B lineage cells in mouse hemopoietic tissues. J Immunol 1984;133:672-7
  • Hu C, Cela RG, Suzuki M, Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proc Natl Acad Sci USA 2011;108:2082-7
  • Santoni A, Riccardi C, Barlozzari T, Natural suppressor cells for murine NK activity. In: Herberman R, editor, NK cells and other natural effector cells. Academic Press; New York; 1982. p. 527-33
  • Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol 2004;172:2731-8
  • Waddington SN, Mitrophanous KA, Ellard FM, Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice. Gene Ther 2003;10:1234-40
  • Lipshutz GS, Titre D, Brindle M, Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol Ther 2003;8:90-8
  • MacKenzie TC, Kobinger GP, Kootstra NA, Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 2002;6:349-58
  • Woo YJ, Raju GP, Swain JL, In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus. Circulation 1997;96:3561-9
  • Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero. Surgery 1999;126:171-7
  • Roybal JL, Endo M, Radu A, Early gestational gene transfer of IL-10 by lentiviral vector can prevent arthritis in a murine model. Mol Ther 2010;18(Suppl 1):S133-4
  • Skopal-Chase JL, Pixley JS, Torabi A, Immune ontogeny and engraftment receptivity in the sheep fetus. Fetal Diagn Ther 2009;25:102-10
  • Plopper C, Alley J, Weir A. Differentiation of tracheal epithelium during fetal maturation in the rhesus monkey Macaca mulatta. Am J Anat 1986;175:59-71
  • Mattar CN, Nathwani AC, Waddington S, Stable human FIX expression after 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-Associated Viral Vector 5 and 8 in Macaques. Mol Ther 2011; In press
  • Tarantal AF, Lee CC, Jimenez DF, Fetal gene transfer using lentiviral vectors: in vivo detection of gene expression by microPET and optical imaging in fetal and infant monkeys. Hum Gene Ther 2006;17:1254-61
  • Garrett D, Larson J, Dunn D, In utero recombinant adeno-associated virus gene transfer in mice, rats, and primates. BMC Biotechnol 2003;3:16-23
  • Tarantal A, Lee C. Long-term luciferase expression monitored by bioluminescence imaging after adeno-associated virus-mediated fetal gene delivery in rhesus monkeys (Macaca mulatta). Hum Gene Ther 2010;21:1-6
  • Tarantal AF, McDonald RJ, Jimenez DF, Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery. Mol Ther 2005;12:87-98
  • Lai L, Davison BB, Veazey RS, A preliminary evaluation of recombinant adeno-associated virus biodistribution in rhesus monkeys after intrahepatic inoculation in utero. Hum Gene Ther 2002;13:2027-39
  • Tarantal AF, Lee CI, Ekert JE, Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): lung-targeting approaches. Mol Ther 2001;4:614-21
  • Hendrickx A, Peterson P. Symposium: reproduction in baboons. Perspectives on the use of the baboon in embryology and teratology research. Hum Reprod Update 1997;3:575-92
  • Musicki B, Pepe G, Albrecht E. Functional differentiation of the placental syncytiotrophoblast: effect of estrogen on chorionic somatomammotropin expression during early primate pregnancy. J Clin Endocrinol Metab 2003;88:4316-23
  • Hendrickx A, Makori N, Peterson P. The nonhuman primate as a model of developmental immunotoxicity. Hum Exp Toxicol 2002;21:537-42
  • Lobach DF, Hensley LL, Ho W, Human T cell antigen expression during the early stages of fetal thymic maturation. J Immunol 1985;135:1752-9
  • Stites D, Carr M, Fundenberg H. Ontogeny of cellular immunity in the human fetus. Development of responses to phytohaemmagglutinin and to allogeneic cells. Cell Immunol 1974;11:257-71
  • Toivanen P, Uksila J, Leino A, Development of mitogen responding T cells and natural killer cells in the human fetus. Immunol Rev 1981;57:89-105
  • Themis M, Schneider H, Kiserud T, Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther 1999;6:1239-48
  • Lipshutz GS, Gruber CA, Cao Y, In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 2001;3:284-92
  • Alonso-Ferrero ME, Valeri A, Yanez R, Immunoresponse against the transgene limits hematopoietic engraftment of mice transplanted in utero with virally transduced fetal liver. Gene Ther 2011;18:469-78
  • Park PJ, Colletti E, Ozturk F, Factors determining the risk of inadvertent retroviral transduction of male germ cells after in utero gene transfer in sheep. Hum Gene Ther 2009;20:201-15
  • Porada CD, Park PJ, Tellez J, Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol Ther 2005;12:754-62
  • Drost JB, Lee WR. Biological basis of germline mutation: comparisons of spontaneous germline mutation rates among drosophila, mouse, and human. Environ Mol Mutagen 1995;25(S2):48-64
  • Lee CC, Jimenez DF, Kohn DB, Fetal gene transfer using lentiviral vectors and the potential for germ cell transduction in rhesus monkeys (Macaca mulatta). Hum Gene Ther 2005;16:417-25
  • Schmidt M, Carbonaro DA, Speckmann C, Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nat Med 2003;9:463-8
  • Carter BJ. Adeno-associated virus vectors in clinical trials. Hum Gene Ther 2005;16:541-50
  • Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 2006;13:1031-49
  • Rivella S, May C, Chadburn A, A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood 2003;101:2932-9
  • Themis M, Waddington SN, Schmidt M, Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 2005;12:763-71
  • Porada CD, Tran N, Eglitis M, In utero gene therapy: transfer and long-term expression of the bacterial neor gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 1998;9:1571-85
  • Kohn DB, Sadelain M, Dunbar C, American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther 2003;8:180-7
  • Sadelain M. Insertional oncogenesis in gene therapy: how much of a risk? Gene Ther 2004;11:569-73
  • Daya S, Cortez N, Berns KI. Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway. J Virol 2009;83:11655-64
  • McCarty DM, Young SM, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Ann Rev Genet 2004;38(s1):819-45
  • Donsante A, Miller DG, Li Y, AAV vector integration sites in mouse hepatocellular carcinoma. Science 2007;317:477
  • Nathwani AC, Rosales C, McIntosh J, Long-term safety and efficacy following systemic administration of a self-complementary AAV Vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. Mol Ther 2011;19:876-85
  • Howe SJ, Mansour MR, Schwarzwaelder K, Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008;118:3143-50
  • Hacein-Bey-Abina S, Garrigue A, Wang GP, Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008;118:3132-42
  • Ott MG, Schmidt M, Schwarzwaelder K, Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006;12:401-9
  • Lipshutz GS, Sarkar R, Flebbe-Rehwaldt L, Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci USA 1999;96:13324-9
  • Bestor TH. Gene silencing as a threat to the success of gene therapy. J Clin Invest 2000;105:409-11
  • Zhang F, Thornhill SI, Howe SJ, Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 2007;110:1448-57
  • Holzinger A, Trapnell BC, Weaver TE, Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995;38:844-50
  • Endo M, Zoltick PW, Peranteau WH, Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter. Mol Ther 2008;16:131-7
  • Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40
  • Foust KD, Nurre E, Montgomery CL, Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2009;27:59-65
  • Halbert CL, Miller AD, McNamara S, Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: implications for gene therapy using AAV Vectors. Hum Gene Ther 2006;17:440-7
  • Zhang F, Thornhill SI, Howe SJ, Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 2007;110:1448-57
  • Buckley SMK, Howe SJ, Sheard V, Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression. Gene Ther 2008;15:1167-75
  • Schneider H, Adebakin S, Themis M, Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. J Gene Med 1999;1:424-32
  • Endo M, Zoltick PW, Chung DC, Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 2007;15:579-87
  • Schneider H, Muhle C, Douar AM, Sustained delivery of therapeutic concentrations of human clotting factor IX – a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 2002;4:46-53
  • Christensen G, Minamisawa S, Gruber PJ, High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Circulation 2000;101:178-84
  • Tran ND, Porada CD, Almeida-Porada G, Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood 2001;97:3417-23
  • Weisz B, David AL, Gregory LG, Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne Muscular Dystrophy. Am J Obstet Gynecol 2005;193:1105-9
  • Jimenez DF, Lee CI, O'shea CE, HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys. Gene Ther 2005;12:821-30
  • Flake A, Zanjani E. In utero transplantation for thalassemia. Ann NY Acad Sci 1998;850(Cooley's Anemia: Seventh Symposium):300-11
  • Westgren M, Ringden O, Eik-Nes S, Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996;61:1176-9
  • Flake AW, Roncarolo MG, Puck JM, Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806-10
  • Krivit W. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol 2004;26:119-32
  • Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669-72
  • Gaspar HB, Parsley KL, Howe S, Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004;364:2181-7
  • Gaspar HB, Bjorkegren E, Parsley K, Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol Ther 2006;14:505-13
  • Aiuti A, Cattaneo F, Galimberti S, Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009;360:447-58
  • Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326:818-23
  • Cavazzana-Calvo M, Payen E, Negre O, Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010;467:318-22
  • Surbek DV, Tercanli S, Holzgreve W. Transabdominal first trimester embryofetoscopy as a potential approach to early in utero stem cell transplantation and gene therapy. Ultrasound in Obstet Gynecol 2000;15:302-7
  • Chan J, Kumar S, Fisk NM. First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells. Hum Reprod 2008;23:2427-37
  • Schoeberlein A, Holzgreve W, Dudler L, In utero transplantation of autologous and allogeneic fetal liver stem cells in ovine fetuses. Am J Obstet Gynecol 2004;191:1030-6
  • Eddleman KA, Malone FD, Sullivan L, Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006;108:1067-72
  • Ditadi A, de Coppi P, Picone O, Human and murine amniotic fluid c-Kit+Lin– cells display hematopoietic activity. Blood 2009;113:3953-60
  • Shaw SS, Bollini S, Abi Nader K, Autologous transplantation of amniotic fluid derived mesenchymal stem cells into sheep fetuses. Cell Transplant 2010 [Epub ahead of print]; doi: 10.3727/096368910X543402
  • Adachi M, Schneck L, Volk BW. Ultrastructural studies of eight cases of fetal Tay-Sachs disease. Lab Invest 1974;30:102-12
  • Kaspar BK, Llado J, Sherkat N, Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003;301:839-42
  • Dindot S, Piccolo P, Grove NC, Intrathecal injection of HDAd vectors results in long-term transgene expression in neuroependymal cells and neurons. Hum Gene Ther 2010 [Epub ahead of print]; doi: 10.1089/hum.2010.147
  • Stitelman DH, Endo M, Bora A, Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector. Mol Ther 2010;18:1615-23
  • Shen JS, Meng XL, Ohashi T, Adenovirus-mediated prenatal gene transfer to murine central nervous system. Gene Ther 2002;9:819-23
  • Gilbert SF. Formation of the Neural Tube. In: Developmental Biology. 6th edition. Sinauer associates; Sunderland: 2000:333-62
  • Byrne C, Hardman M, Nield K. Covering the limb – formation of the integument. J Anat 2003;202:113-23
  • Shen JS, Meng XL, Maeda H, Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease. J Gene Med 2004;6:1206-15
  • Shen JS, Meng XL, Yokoo T, Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease. J Gene Med 2005;7:540-51
  • Rahim AA, Wong AM, Hoeffer K, Efficient CNS, PNS, and visceral gene delivery following fetal and neonatal intravenous administration of AAV9. Hum Gene Ther 2010;21:505-6
  • Sylvester KG, Yang EY, Cass DL, Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 1997;32:964-9
  • Luton D, Oudrhiri N, de Lagausie P, Gene transfection into fetal sheep airways in utero using guanidinium-cholesterol cationic lipids. J Gene Med 2004;6:328-36
  • Harrison MR, Keller RL, Hawgood SB, A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med 2003;349:1916-24
  • U.S. National Institutes of Health Recombinant DNA Advisory Committee. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. Hum Gene Ther 2000;11:1211-29
  • Noble R, Rodeck CH. Ethical considerations of fetal therapy. Best Pract Res Clin Obstet Gynaecol 2008;22:219-31
  • Deichmann A, Hacein-Bey-Abina S, Schmidt M, Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 2007;117:2225-32
  • Han XD, Lin C, Chang J, Fetal gene therapy of alpha-thalassemia in a mouse model. Proc Natl Acad Sci USA 2007;104:9007-11
  • Meertens L, Mahieux R, Mauclere P, Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype. J Virol 2002;76:259-68
  • Lutzko C, Kruth S, Abrams-Ogg AC, Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood 1999;93:1895-905
  • Larson J, Morrow S, Happel L, Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997;349:619-20

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.